Bio-Gene Technology (ASX:BGT) Accumulated Depreciation: A$-0.05 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Bio-Gene Technology Accumulated Depreciation?

Bio-Gene Technology ASX:BGT Accumulated Depreciation is A$-0.05 Mil as of Jun. 2026. The stock has 2 warning signs investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Bio-Gene Technology's quarterly accumulated depreciation increased from Jun. 2025 (A$-0.04 Mil) to Dec. 2025 (A$ Mil) but then stayed the same from Dec. 2025 (A$ Mil) to Jun. 2026 (A$-0.05 Mil).

Bio-Gene Technology's annual accumulated depreciation increased from Jun. 2024 (A$-0.04 Mil) to Jun. 2025 (A$-0.04 Mil) and increased from Jun. 2025 (A$-0.04 Mil) to Jun. 2026 (A$-0.05 Mil).

Bio-Gene Technology Accumulated Depreciation Related Terms

Bio-Gene Technology Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for Bio-Gene Technology's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Gene Technology Accumulated Depreciation Chart

Bio-Gene Technology Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.03 -0.04 -0.04 -0.04 -0.05

Bio-Gene Technology Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Dec24 Jun25 Dec25 Jun26
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -0.04 - -0.05

Bio-Gene Technology Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of A$-0.05 Mil mean?
Bio-Gene Technology (ASX:BGT) has a Accumulated Depreciation of A$-0.05 Mil as of Jun. 2026. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Bio-Gene Technology and its competitors.
Is Bio-Gene Technology's Accumulated Depreciation too high?
Bio-Gene Technology's current Accumulated Depreciation is A$-0.05 Mil.
How does Bio-Gene Technology's Accumulated Depreciation compare to VRTX and REGN?
Bio-Gene Technology's Accumulated Depreciation of A$-0.05 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Biotechnology company?
A good Accumulated Depreciation depends on the Biotechnology industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on Bio-Gene Technology and its competitors. Bio-Gene Technology's current Accumulated Depreciation is A$-0.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Gene Technology stock overvalued right now?
Bio-Gene Technology (ASX:BGT) has a current Accumulated Depreciation of A$-0.05 Mil. The current Accumulated Depreciation is A$-0.05 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For Bio-Gene Technology (ASX:BGT), the current Accumulated Depreciation is A$-0.05 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bio-Gene Technology Business Description

Address 400 Collins Street, Level 6, Melbourne, VIC, AUS, 3000
Bio-Gene Technology Ltd is an Australian company developing novel bio-insecticides to address the challenges of insecticide resistance and toxicity. Its products are based on a naturally occurring class of compounds to overcome resistance to control pests with minimal impact on human health and the environment. Bio-Gene's products have multiple applications across public health, crop protection, grain storage, and consumer use. The company operates in one business segment, being the conduct of research and development activities in the discovery of novel insecticides.